C11493: Automatic External Defibrillator for ICD PatientsNovelty:
This technology is an automatic external defibrillator for patients with implantable cardioverter defibrillators (ICDs) to avoid electromagnetic interference during the post-procedural period after surgical and endoscopic procedures.
Value Proposition:
Many surgical procedures require deactivation of ICDs if a patient requires one. During this time, the patient’s heart can suddenly stop and, therefore, these procedures must be carried out in specialized operating rooms with staff trained in advanced cardio life support. This invention monitors the patient and automatically treats ventricular arrhythmias. Unique features of the device allow its use during the post-procedural period on patients with ICDs, while maintaining patient comfort. Advantages of this invention include:
• Decreased mortality rate
• Smaller device size than commonly used external defibrillators
• Portable wireless monitor for hospital staff
• Lower operating room costs and less liability
Technical Details:
Johns Hopkins researchers have developed a novel automatic external defibrillator for patients with ICDs. The device builds upon the current Zoll LifeVest Wearable Defibrillator Monitor, which is comfortable for the patient post-procedure. The pads are designed to minimize surgical wound interference, as well as maximize the device distance from the ICD while maintaining the industry standard contact area. The device also features a warning label reminding clinical staff to reactivate the ICD before device removal and an alarm when a shock will be administered. This shock occurs automatically unless aborted by a hospital professional.
Looking for Partners:
To develop and commercialize the technology as an improved automatic external defibrillator for patients with ICDs.
Stage of Development:
Proof of Concept
Data Availability:
Under CDA/NDA
Publications/Associated Cases:
Not available at this time.
